Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

OK-432 develops CTL and LAK activity in mononuclear cells from regional lymph nodes of lung cancer patients.

International journal of immunopharmacology - 1 Aug 1998

Takahashi K, Harauchi D, Kimura S, Saito S, Monden Y

Abstract excerpt

We examined the effect of OK-432 on induction of cytotoxic T lymphocytes (CTL) directed against autologous tumor cells (ATC) and lymphokine-activated killer (LAK) cells from mononuclear cells separated from regional lymph node cells (RLMNCs) of 49 lung cancer patients. We also examined the phenotypic changes of RLMNCs during incubation with or without OK-432. Significant CTL activity and LAK activity against ATC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HLA-DR Antigens

Share to Interleukin-2

Share to Lung Neoplasms

Share to Phenotype

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 9778099
DOI: 10.1016/s0192-0561(98)00011-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

OK-432 develops CTL and LAK activity in mononuclear cells from regional lymph nodes of lung cancer patients.PMID 9778099Read ↗

Effects of OK-432 on in vitro secondary responses of the non-adherent cells to IL-2 and OK-432 in cancer patients without tumor burden.Semantic proximity Read ↗

Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer.Semantic proximity Read ↗

Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin 2.Semantic proximity Read ↗

Characterization of OKT3-initiated lymphokine-activated effectors expanded with interleukin 2 and tumor necrosis factor alpha.Semantic proximity Read ↗

Effects of interleukin-12 on in vitro culture with interleukin-2 of regional lymph node lymphocytes from lung cancer patients.Semantic proximity Read ↗

Effects of OK-432 on the proliferation and cytotoxicity of lymphokine-activated killer (LAK) cells.Semantic proximity Read ↗

Prospects for Combined Treatment of Non-Small Cell Lung Cancer Using Autologous Activated LymphocytesSemantic proximity Read ↗

Autologous tumor cell killing activity of tumor-associated lymphocytes in patients with head and neck carcinomas.Semantic proximity Read ↗

Granulocyte-macrophage colony-stimulating factor augments lymphokine-activated killer activity from pleural cavity mononuclear cells of lung cancer patients without malignant effusion.Semantic proximity Read ↗

Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor.Semantic proximity Read ↗

Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.Semantic proximity Read ↗

Synergistic actions of picibanil (OK-432) on recombinant interleukin-2 induction of tumor-infiltrating lymphocyte expansion, cytotoxicity, and phenotypic differentiation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.